The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort

NCT ID: NCT06904560

Last Updated: 2025-04-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-01

Study Completion Date

2025-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

patients underwent phacoemulsification , balanced saline solution used during the operation will be at room temperature in one group and cool 2.7 c in the other group. the patients will be followed for 3 months after phacoemulsification regarding corneal endothelial cells and anterior segment inflammatory signs

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Corneal Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group 1

patients underwent phacoemulsification , balanced saline solution at room temperature will be used for irrigation

Group Type OTHER

phacoemulsification

Intervention Type OTHER

one group with BSS at room temperature and the other group with cold BSS

group 2

patients underwent phacoemulsification , balanced saline solution with low (cold ) temperature will be used for irrigation

Group Type EXPERIMENTAL

phacoemulsification

Intervention Type OTHER

one group with BSS at room temperature and the other group with cold BSS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

phacoemulsification

one group with BSS at room temperature and the other group with cold BSS

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with cataract
* more than 40 years
* no glaucoma
* no retinal abnormalities
* no retinal abnormalities

Exclusion Criteria

patients with corneal diseases patients less than 40 patients with previous eye surgery
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hany Mahmoud,MD

assistant professor of ophthalmology

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hany Mahmoud

Role: CONTACT

01024368111

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sohag-med-25-1-5PD

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.